SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 31st, 2024 • Edesa Biotech, Inc. • Pharmaceutical preparations • Ontario
Contract Type FiledOctober 31st, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of October 30, 2024, between Edesa Biotech, Inc., a British Columbia corporation (the “Company”), and Pardeep Nijhawan Medicine Professional Corporation (the “Purchaser”).
FORM OF WARRANT TO PURCHASE COMMON SHARE PURCHASE OF Edesa Biotech, Inc.Edesa Biotech, Inc. • October 31st, 2024 • Pharmaceutical preparations
Company FiledOctober 31st, 2024 IndustryTHIS COMMON SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Pardeep Nijhawan Medicine Professional Corporation or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time from the date hereof until 5:00 p.m. (Toronto time) on __________ (the “Termination Date”), but not thereafter, to subscribe for and purchase from Edesa Biotech, Inc., a British Columbia corporation (the “Company”), up to __________ Common Shares under this Warrant (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).